This COVID-19 Vaccine Can Be Effective for India
Oxford University’s COVID-19 vaccine candidate is 90% effective in preventing the virus when administered as a half dose followed by a full dose at least one month apart.
The interim data has suggested that there will be 70% protection, but the researchers say the figure may be as high as 90% by tweaking the dose, as reported by the BBC.
When someone is given two full doses one month apart, it is 62% effective.
When combined, on average, the vaccine prevents COVID-19 in 70% of the cases.
The results can be considered positive, but other companies such as Pfizer and Moderna vaccines showed 95% protection. However, as per reports, the Oxford one is cheaper and easier to store and get to every corner of the world than the other two. This might be beneficial for a country like India.
These are preliminary results from late-stage trials in Britain and Brazil, but late-stage trials are on in India as well. They are being conducted by the Serum Institute of India or SII, which has parallelly been manufacturing millions of doses to keep ready.
- COVID Vaccine
- COVID vaccine India
- Oxford COVID vaccine